Status:
UNKNOWN
Correlation of Gene Status and Clinical Outcomes in ESCC
Lead Sponsor:
LiuJunFeng
Collaborating Sponsors:
OrigiMed
Conditions:
Prognosis of Patients With ESCC
Eligibility:
All Genders
30-80 years
Brief Summary
The incidence of esophageal squamous cell carcinoma is highly regional and familial. The current treatment plan is based on the stage and location of the tumor.By studying the relationship between the...
Eligibility Criteria
Inclusion
- Esophageal cancer patients who underwent surgery treatment, and postoperative pathological diagnosis was squamous cell carcinoma. Patients with ESCC have complete clinical information.
Exclusion
- Patients who also suffering from other tumors.
Key Trial Info
Start Date :
December 26 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2019
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT03831828
Start Date
December 26 2018
End Date
April 1 2019
Last Update
February 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Junfeng Liu
Shijiazhuang, Hebei, China, 050000